Jasper Therapeutics

Company snapshot

Jasper Therapeutics is a biotechnology company on a mission to make safer and potentially curative therapy possible for more patients in need. We are bringing together a team of biotech veterans, leading academic institutions and a strong syndicate of healthcare-focused investors to achieve our vision of developing new therapies for diseases of mast and stem cells, and safer and more effective con

• 13 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 US patent(s) indexed to this assignee profile.
• 13 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Jasper Therapeutics. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Jasper Therapeutics.

1. Jun 8, 2026 Clinical update

   JSP-CP-011 — Phase 2

2. Jun 8, 2026 Clinical update

   JSP-CP-012 — Phase 1

3. Jun 8, 2026 Clinical update

   EPINEPHRINE , Briquilimab — Phase 2

4. Jun 8, 2026 Clinical update

   Nicotine patch — Phase 3

5. Jun 8, 2026 Clinical update

   Nelfinavir and Omeprazole — Approved

View all clinical trial activity →

• What is Jasper Therapeutics?

  Jasper Therapeutics is a biotech organization headquartered in Redwood City, USA. It trades on NYSE under ticker JSPR. Primary therapeutic focus areas include Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, allergic asthma, Chronic Urticaria, Allergic Asthma. NovaPhar

• Is Jasper Therapeutics publicly traded?

  Yes. Jasper Therapeutics is listed with ticker JSPR on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Jasper Therapeutics develop or market?

  We link 13 drug profile(s) where Jasper Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/jasper-therapeutics#company-drugs.

• What are the latest developments for Jasper Therapeutics?

  In the last 12 months our linked public records show 13 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Jasper Therapeutics focus on?

  Jasper Therapeutics focuses on Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, allergic asthma based on our analysis of their pipeline programs and drug development activities.